Norway vs Singapore: Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
Norway
96.0%
in 2025
Singapore
96.0%
in 2025
Norway rank
40th
Singapore rank
40th
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) over time
- Norway
- Singapore
How they compare
Norway currently reports 96.0% against 96.0% in Singapore, a difference of 0.0%.
Across all 26 years both countries report, Singapore has been ahead every year.
Norway ranks 40th and Singapore ranks 40th of 194 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 95.6% | 95.6% | Singapore |
| 2010s | 9.6% | 96.4% | 86.8% | Singapore |
| 2020s | 96.2% | 96.5% | 0.3% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b (hepb3) immunization coverage among 1-year-olds (%), Norway or Singapore?
- Norway, at 96.0% against 96.0% in Singapore as of 2025.
- What is the difference in hepatitis b (hepb3) immunization coverage among 1-year-olds (%) between Norway and Singapore?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Singapore?
- 26 years are reported by both, from 2000 to 2025.
- How do Norway and Singapore rank globally for hepatitis b (hepb3) immunization coverage among 1-year-olds (%)?
- Norway ranks 40th and Singapore ranks 40th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.